Fact CheckerSign in

NCT05331911RecruitingPhase 4

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane

Source: ClinicalTrials.gov · Last updated 30 Nov 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
500 (estimated)
First submitted
29 Mar 2022
Start date
26 Apr 2022
Primary completion date
31 Dec 2026
Lead sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
NCT number
NCT05331911

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 500
  • From 26 Apr 2022 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recurrent tumor or repeat surgery
  • Incomplete data collection before the surgery
  • Palliative treatment after surgery
  • Emergency surgery

Other illness

  • Severe mental disorder
  • Allergy to any of the drugs used in this study
  • simultaneous treatment of other malignancies

Other

  • Pregnant or lactating women
  • Morbidly obese
  • Biopsy cases
  • Combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine
  • Diagnosed as benign liver tumor

Who the study is looking for

  • Twenty to eighty-year-old.
  • ASA class I-III.
  • Patients undergoing partial hepatectomy for hepatocellular carcinoma under general anesthesia.

Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaohsiung Medical University Chung-Ho Memorial Hospital
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.